AGENDA

Tuesday 2 October 2018
08.30 – 09.00 Registration (tea and coffee)
09.00 – 09.25 Welcome from leadership
09.25 – 12.00 Enabling Early Detection Through Early Disease Models 

(Session will have a short break between 10.20 – 10.40)

Chairs:

·         Owen Sansom, CRUK, Beatson Institute

·         Pepper Schedin, Oregon Health and Science University (TBD)

Speakers:

·         TBA

12.00 – 13.00

13.00 – 14.00

Lunch Break – Networking

Networking Session

14.00 – 16.35 Population Risk Stratification for Early Detection; Discovery to Implementation

(Session will have a short break between 14.55 – 15.15)

Chairs:

·         Gareth Evans, University of Manchester

·         Jackie Shannon, Oregon Health and Science University

Speakers:

·         TBA

17.30 – 19.30 Reception – Knight Cancer Research Building
Wednesday 3 October 2018
08.30 – 09.00 Tea and coffee
09.00 – 09.25 Welcome & Recap
09.25 – 12.00 The Signatures of Early and Pre-Cancer; Predictive Early Detection

(Session will have a short break between 10.20 – 10.40)

Chairs:

·         Christina Curtis, Stanford

·         Joe Gray, Oregon Health and Science University

 Speakers:

·         TBA

12.00 – 13.30 Lunch Break
13.30 – 16.05 Data Science for Early Detection

(Session will have a short break between 14.25 – 14.45)

Chairs:

·         Brendan Delaney, Imperial College

·         Parag Mallick, Stanford

Speakers:

·         TBA

17.00 – 19.00 Reception – Location TBA
Thursday 4 October 2018
08.30 – 09.00 Tea and coffee
09.00 – 09.25 Welcome
09.25 – 12.00 Novel Technology Accelerating Early Detection

(Session will have a short break between 10.30 – 10.50)

Chairs:

•         Utkan Demirci, Stanford

•         Mike Heller, Oregon Health and Science University

Speakers:

•         TBA

12.00 – 13.30 Lunch Break
13.30 – 15.30 Final Discussion: Topic TBD 

(Session will allow 20 minutes per topic and have a short break between 14.10 – 14.30)

Chairs:

•         Jack Cuzick, Queen Mary University

•         Sanjiv Sam Gambhir, Stanford

•         Paul Spellman, Oregon Health and Science University

The purpose of the session is to:

•         Explore the challenges and barriers to progress which have emerged over the course of the conference

•         Identify where gaps exist in our knowledge and expertise

•         Define these roadblocks as tractable challenges and as calls-to-action for the whole cancer research community

•         Explore how these challenges might be addressed through collaboration and integration of ideas from multiple disciplines, research areas and sectors

•         Consider the above with a mind-set of achieving meaningful progress towards impact on health

•         Provide input which will influence funders’ thinking around how they should develop and implement funding strategy in this field

15.30 Meeting close